Randox Toxicology has launched its Mitragynine ELISA for the detection of the herbal drug, Kratom.
Kratom is a herbal drug which originates from Mitragyna speciosa; an uncontrolled plant found in south east Asia.
The drug has gained significant popularity in recent years due to its widespread availability on the internet and in head shops. It is marketed as a way to combat fatigue, pain and depression.
The new ELISA developed by Randox Toxicology is the world’s first immunoassay drug test for Kratom; providing a rapid solution for the detection of Mitragynine and its metabolites.
Several cases of psychosis resulting from the use of Kratom have been reported, with individuals addicted to the drug exhibiting psychotic symptoms such as hallucinations, delusion, and confusion.
The novel ELISA, developed by Randox Toxicology, can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing valuable information for further analysis.
